EU Novel Food and US DSHEA: Documentation Pathways for Botanical Extract Imports

The EU and the US ask different first questions about a botanical extract. In the EU, the threshold question is whether the ingredient is a novel food under Regulation (EU) 2015/2283, which turns on a significant history of consumption in the EU before 15 May 1997. In the US, the question is whether the material is a dietary ingredient under DSHEA and, if it is a new dietary ingredient, whether a 75-day pre-market notification is required. Neither pathway is a certificate a supplier can simply issue; both are documentation exercises that start with the ingredient identity, the plant part and the manufacturing process.

Key takeaways
  • Establish ingredient identity and history-of-use evidence before discussing market entry.
  • EU: Regulation (EU) 2015/2283 and the Novel Food Catalogue are the starting references.
  • US: DSHEA, the 15 October 1994 grandfathering date and NDI notification obligations.
  • GRAS applies to conventional foods, not to dietary supplement ingredients as such.

1. Why the two frameworks start differently

The EU framework is ingredient-and-history led: an ingredient without a documented history of significant consumption in the EU before 15 May 1997 generally needs authorisation as a novel food. The US framework is category-and-notification led: a dietary ingredient marketed in the US before 15 October 1994 is generally grandfathered, while a new dietary ingredient requires a notification to FDA at least 75 days before introduction.

For a supplier, the practical message is that a generic “compliant with EU and US regulations” statement is not useful. What an importer needs is evidence tied to a specific botanical name, plant part, extraction process and intended use.

QuestionEUUS
Core referenceRegulation (EU) 2015/2283; Novel Food CatalogueDietary Supplement Health and Education Act (DSHEA, 1994)
Key date15 May 1997 (significant consumption in the EU)15 October 1994 (marketed as a dietary ingredient)
Typical evidenceHistory-of-use dossier, consumption data, identity and compositionGrandfathering evidence or a New Dietary Ingredient notification
Pre-market stepNovel food authorisation where requiredNDI notification at least 75 days before introduction, where required

2. The EU: assembling a history-of-use position

The Novel Food Catalogue is a useful orientation tool but is not a legal determination. A defensible position usually combines the botanical identity, the plant part, the manufacturing process, the composition and documented evidence of consumption as a food in the EU before the cut-off date. A change of plant part or a novel extraction process can change the assessment even for a familiar plant.

Where authorisation is required, the application needs a structured dossier covering identity, production process, composition, specifications, proposed uses and use levels, and safety information. A supplier should be able to supply the technical annexes even if the importer or a specialist consultancy files the application.

  • Latin binomial, plant part, and the exact extraction and purification process.
  • Compositional data and a versioned specification with analytical methods.
  • Documented history of food use in the EU before 15 May 1997, where relied upon.
  • Proposed conditions of use, use levels and target consumer groups.

3. The US: DSHEA, NDIs and cGMP

Under DSHEA, a dietary supplement containing a new dietary ingredient requires a notification submitted to FDA at least 75 days before the product is introduced, unless the ingredient has been present in the food supply as an article used for food in a form that has not been chemically altered. Grandfathering evidence should be contemporaneous and tied to the same ingredient form.

Manufacturers are also subject to the dietary supplement cGMP requirements in 21 CFR Part 111, which puts the emphasis on written specifications, testing and batch records. GRAS conclusions relate to conventional food use and should not be presented as a substitute for a dietary supplement determination.

  • Determine whether the ingredient is an old dietary ingredient or a new dietary ingredient.
  • Where required, prepare the NDI notification with identity, history and safety basis.
  • Maintain cGMP documentation: specifications, test methods, batch records and COAs.
  • Keep health claims and labelling separate from the ingredient qualification question.

4. The document set an importer should request

Regardless of market, the underlying technical package is largely the same. Ask for it once, in a consistent format, and reuse it for both dossiers. Our team assembles the same package for every botanical ingredient we qualify, because it also serves as the quality record for repeat purchasing.

DocumentWhat it establishesUsed for
Versioned specification sheetIdentity, markers, limits and methodsBoth markets
Batch-specific COAWhat one lot actually wasBoth markets
Process flow and solvent listWhether the ingredient is chemically alteredEU novel food, US NDI
Origin and traceability recordSpecies, plant part, region, harvest lotBoth markets
History-of-use evidencePre-cut-off consumption or marketingEU and US respectively
Contaminant and stability dataSafety and shelf-life basisBoth markets

5. Labelling, claims and common mistakes

Ingredient qualification is not the same as a claim review. In the EU, nutrition and health claims are governed by Regulation (EC) No 1924/2006; in the US, structure/function claims and disclaimer requirements sit alongside FDA and FTC rules. A technically compliant extract can still carry a non-compliant label.

Three recurring mistakes are worth flagging: treating a GRAS conclusion as a supplement approval, assuming a familiar plant automatically covers a new plant part or a novel extract, and relying on a supplier’s generic compliance statement instead of a document set tied to the specific grade.

  • Keep ingredient qualification, product labelling and marketing claims as separate reviews.
  • Re-assess when the plant part, extraction solvent or purification process changes.
  • Tie every compliance statement to a specific specification version and grade.
  • Have the destination-market regulatory reviewer confirm the final position.

6. A practical sequence for a new ingredient

A short, ordered sequence avoids the most expensive mistake in this area: developing a finished product around an ingredient that cannot be documented in the target market. Start with identity and process, then the regulatory position, then the commercial specification.

  • Define botanical identity, plant part, process and grade, and freeze them in a specification.
  • Assess the EU novel food position and the US dietary ingredient/NDI position in parallel.
  • Collect the technical package: COA, process flow, origin record, contaminants and stability.
  • Only then agree commercial terms, MOQ and lead time through a quote request.

Frequently asked questions

Can a supplier certify that an extract is not a novel food in the EU?

No. A supplier can provide identity, composition, process and history-of-use evidence, but the determination depends on the intended use and the destination-market assessment. Treat the Novel Food Catalogue as guidance, not as an approval.

Does GRAS status make a botanical extract acceptable in a US dietary supplement?

No. GRAS conclusions concern conventional food use. Dietary supplement ingredients are assessed under DSHEA, including grandfathering or NDI notification obligations, and products are subject to 21 CFR Part 111 cGMP.

Why does the extraction process matter for a regulatory assessment?

A new plant part, solvent or purification step can change composition enough to alter the assessment. Evidence of historical use generally has to match the ingredient form being placed on the market.

What is the minimum document set to request from a supplier?

A versioned specification with methods, a batch-specific COA, a process flow with solvent list, origin and traceability records, contaminant and stability data, and any history-of-use evidence relevant to the target market.

Need the documentation for your project?

Tell us the ingredient, target specification, quantity and destination market. Our team will send a specification sheet, COA sample and a quotation within 24 hours on working days.

Request a Quote Browse Products

Related topic: EU Novel Food and US DSHEA documentation for botanical extract imports

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top